July 16, 2026

Kairos Pharma announces interim Phase I data for ENV-105 in NSCLC

​Kairos Pharma has reported interim safety results from its ongoing Phase I trial of ENV-105, along with AstraZeneca's Tagrisso, in...

July 16, 2026

Smith+Nephew unveils Lynx Coblation Laryngeal Wand for laryngology

​Smith+Nephew has commercially launched its Lynx Coblation Laryngeal Wand, a device developed for ENT surgeons carrying out laryngology procedures.The post...

July 16, 2026

Harbour BioMed and Kelun-Biotech receive China IND approval for asthma therapy

​Harbour BioMed and Kelun-Biotech have received approval from China’s NMPA for their IND application for the HBM7575/SKB575 bispecific antibody intended...

July 15, 2026

Sound Pharmaceuticals concludes subject enrolment for SPI-1005 trial

​Sound Pharmaceuticals has concluded subject enrolment for its second Phase III clinical trial assessing SPI-1005 in adults with probable or...

July 15, 2026

Neuraptive secures exclusive licence from Washington University for nerve device

​Neuraptive Therapeutics has secured an exclusive licence from Washington University in St. Louis for a bioresorbable wireless electronic stimulation device...

July 15, 2026

Innovent licenses IBI355 rights to Spero for up to $1.1bn

​Innovent Biologics has granted Spero Therapeutics an exclusive licence deal to develop and commercialise IBI355 outside Greater China.The post Innovent...

July 14, 2026

Claria Medical secures FDA De Novo classification for hysterectomy device

​Claria Medical has secured De Novo classification and marketing authorisation from the US FDA for its Claria System, a device...

July 14, 2026

First participant dosed in Ionis’ Phase I-II ASCEND study

​Ionis Pharmaceuticals has dosed the first participant in its Phase I-II ASCEND trial evaluating ION337 for children with Dravet syndrome.The...

July 14, 2026

Cellares and Sonoma partner to automate cell therapy manufacturing

​Cellares and Sonoma Biotherapeutics have partnered to automate the manufacturing of the latter’s SBT-77-7101 programme using the Cellares Cell Shuttle...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.